RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary

RenovoRx

14/08/2025 22:01

RenovoRx Inc RNXT.OQ reported a quarterly adjusted loss of 8 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of four analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -11 cents to -7 cents per share.

Revenue was $422.00 thousand​; analysts expected $329.67 thousand.

RenovoRx Inc's reported EPS for the quarter was a loss of 8 cents​.

The company reported a quarterly loss of $2.9 million.

RenovoRx Inc shares had fallen by 7.2% this quarter and lost 5.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 15.9% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

Wall Street's median 12-month price target for RenovoRx Inc is $3.75, about 67.5% above its last closing price of $1.22

This summary was machine generated from LSEG data August 14 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.08
-0.08
Met
Mar. 31 2025
-0.08
-0.08
Met
Dec. 31 2024
-0.11
-0.13
Missed
Sep. 30 2024
-0.12
-0.10
Beat